[1]
M. Kiszka, “DUAL TARGETED THERAPY IN CROHN’S DISEASE – CURRENT OPTIONS, CLINICAL EFFICACY, AND SAFETY PROFILE”, IJITSS, vol. 1, no. 4(52), Nov. 2026, doi: 10.31435/ijitss.4(52).2026.6923.